CogENT Therapeutics
Hayward
About CogENT Therapeutics
Cogent Therapeutics is a provider of services related to ear, nose, and throat (ENT) disorders. It develops innovative bio-material and device services focused on improving the lives of patients suffering from ENT disorders. The company's product, XeroGel, a nasal/sinus polymer pack, is a combination of chitosan (hemostatic biopolymer) and polyethylene glycol (synthetic polymer); The biomaterial is used to minimize bleeding, separate tissues, prevent adhesion formation between mucosal surfaces, aid in the natural wound healing process, and treat epistaxis (nose bleeds).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Website: cogent-tx.com
- Phone: (650) 450-4956
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cogent-therapeutics-1585681 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.